Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Moving Past the Pandemic: Setting a Future Focus

A message from the Chief Executive Officer
Summer 2022

In Harm’s Way: The Impact of Violence in Workers’ Comp

Types of violence that can impact workers’ comp
Summer 2022

The Cannabis Question: Marijuana and Workplace Safety?

With greater legalization and public approval, the question of safety grows more important.
Summer 2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Digital Therapeutics: The Promise of Better Health Outcomes for Injured Workers

What they are, the benefits, how they’re currently covered by insurers, and future outlooks.
Apr 2025

Massachusetts Considers Reimbursement, California Could Reject Medical Recommendation

A bill in Massachusetts could require insurers to pay for marijuana, while ACOEM recommends against marijuana for chronic pain guidelines.
Apr 2025

WCRI Publishes Study on Degenerative and Comorbid Conditions

Approximately 38.8% of claims had one or more comorbidities, based on an analysis of 930,000 claims with at least 7 days lost time across 32 states.
Apr 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.
May 2020

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020
1 … 15 16 17 18 19 … 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle